檢索結果 - Robert Bissonnette

Refine Results
  1. 1
    Socioeconomic Burden of Immune-Mediated Inflammatory Diseases -- Focusing on Work Productivity and Disability

    Socioeconomic Burden of Immune-Mediated Inflammatory Diseases -- Focusing on Work Productivity and Disability 由 Philip Jacobs, Robert Bissonnette, Lyn Guenther

    出版 2011
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial

    Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial 由 Catherine Maari, Philippe Marchessault, Robert Bissonnette

    出版 2014
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  3. 3
    IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

    IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies 由 Andrew Blauvelt, Mark Lebwohl, Robert Bissonnette

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis

    Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis 由 Shunya Mashiko, Heena Mehta, Robert Bissonnette, Marika Sarfati

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent

    Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent 由 Paul S. Yamauchi, Robert Bissonnette, Henrique D. Teixeira, Wendell C. Valdecantos

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study

    Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study 由 Robert Bissonnette, Yves Poulin, Lyn Guenther, Charles Lynde, Chantal Bolduc, Simon Nigen

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis

    Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis 由 Shunya Mashiko, Salim Bouguermouh, Manuel Rubio, Nobuyasu Baba, Robert Bissonnette, Marika Sarfati

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent

    Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent 由 Robert Bissonnette, Linda Stein Gold, David S. Rubenstein, Anna M. Tallman, April W. Armstrong

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema

    Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema 由 Diamant Thaçi, Melinda Gooderham, Paola Lovato, Daniel Elenius Madsen, Anders Soehoel, Robert Bissonnette

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis

    Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis 由 Robert Bissonnette, Jean‐Claude Tardif, François Harel, Joséphine Pressacco, Chantal Bolduc, Marie‐Claude Guertin

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison

    Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehi... 由 Brigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, Benjamin Barankin, Charles Lynde, Nabil Kerrouche, Jerry Tan

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis

    A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis 由 Robert Bissonnette, Robert S. Call, Tooraj Joseph Raoof, Zhaoyin Zhu, Swamy Yeleswaram, Xiaohua Gong, Mark Lee

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

    A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis 由 W.C. Ports, Sairah Khan, Shu-Ping Lan, M. Lamba, Chantal Bolduc, Robert Bissonnette, Kim Papp

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis

    Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety... 由 Robert Bissonnette, David M. Pariser, Norman Wasel, Joana Gonçalves, Robert M. Day, Rongdean Chen, Michael Sebastian

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial

    Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial 由 Robert Bissonnette, Genhui Chen, Chantal Bolduc, Catherine Maari, Michael P. A. Lyle, Liren Tang, John Webster, Youwen Zhou

    出版 2010
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  16. 16
    Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)

    Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE) 由 Diamant Thaçi, John M. Humeniuk, Yvonne Frambach, Robert Bissonnette, J. John Goodman, Santosh Shevade, Yifan Gong, C. Papavassilis

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris

    Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis V... 由 Robert Bissonnette, Mayte Suárez‐Fariñas, Xuan Li, Kathleen M. Bonifacio, Carrie Brodmerkel, Judilyn Fuentes‐Duculan, James G. Krueger

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

    Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council 由 Yael Renert‐Yuval, Jacob P. Thyssen, Robert Bissonnette, Thomas Bieber, Kenji Kabashima, DirkJan Hijnen, Emma Guttman‐Yassky

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes

    The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes 由 Jaehwan Kim, Robert Bissonnette, Jongmi Lee, Joel Corrêa da Rosa, Mayte Suárez‐Fariñas, Michelle A. Lowes, James G. Krueger

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis ( <scp>ADVISE</scp> )

    Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis ( <scp>ADVISE</scp> ) 由 Jonathan I. Silverberg, Robert Bissonnette, Leon Kircik, Dédée F. Murrell, Andrew Selfridge, Kris Liu, Gurpreet S. Ahluwalia, Emma Guttman‐Yassky

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: